Division of Molecular and Life Sciences, Hanyang University, Ansan 426-791, Korea.
Korean J Physiol Pharmacol. 2008 Aug;12(4):211-6. doi: 10.4196/kjpp.2008.12.4.211. Epub 2008 Aug 31.
TREK (TWIK-RElated K(+) channels) and TRAAK (TWIK-Related Arachidonic acid Activated K(+) channels) were expressed in COS-7 cells, and the channel activities were recorded from inside-out membrane patches using holding potential of -40 mV in symmetrical 150 mM K(+) solution. Intracellular application of an oxidizing agent, 5,5'-dithio-bis (2-nitrobenzoic acid) (DTNB), markedly decreased the activity of the TREK2, and the activity was partially reversed by the reducing agent, dithiothreitol (DTT). In order to examine the possibility that the target sites for the oxidizing agents might be located in the C-terminus of TREK2, two chimeras were constructed: TREK2 (1-383)/TASK3C and TREK2 (1-353)/TASK3C. The channel activity in the TREK2 (1-383)/TASK3C chimera was still inhibited by DTNB, but not in the TREK2 (1-353)/TASK3C chimera. These results indicate that TREK2 is inhibited by oxidation, and that the target site for oxidation is located between the amino acid residues 353 and 383 in the C-terminus of the TREK2 protein.
TREK(TWIK 相关的钾通道)和 TRAAK(TWIK 相关的花生四烯酸激活的钾通道)在 COS-7 细胞中表达,并用 150mM K+ 溶液中的 -40mV 保持电位记录膜片钳内面向外的膜片上的通道活性。细胞内应用氧化剂 5,5'-二硫代双(2-硝基苯甲酸)(DTNB)可显著降低 TREK2 的活性,而还原剂二硫苏糖醇(DTT)可部分逆转其活性。为了研究氧化剂的作用靶点是否位于 TREK2 的 C 末端,构建了两个嵌合体:TREK2(1-383)/TASK3C 和 TREK2(1-353)/TASK3C。TREK2(1-383)/TASK3C 嵌合体的通道活性仍被 DTNB 抑制,但 TREK2(1-353)/TASK3C 嵌合体则不受抑制。这些结果表明 TREK2 可被氧化抑制,而氧化作用的靶点位于 TREK2 蛋白 C 末端的 353 到 383 位氨基酸之间。